IL-1 pathway may stop Candida fungus from turning fatal in weakened immunity

A recently published study in Nature Microbiology reveals a crucial immune pathway that prevents a typically harmless fungus, Candida albicans, from causing fatal infections in vulnerable individuals. Led by researchers at King's College London, the findings highlight the significance of the IL-1 immune pathway in containing the spread of Candida albicans when the immune system is weakened, such as in patients undergoing chemotherapy or living with HIV.

The study, which involved genetically modified mice lacking IL-1 production, demonstrated that these mice were prone to severe disease when exposed to Candida albicans. By injecting IL-1-deficient mice with a drug that depleted neutrophils, the researchers observed that the fungus spread throughout the body, ultimately leading to fatal disease.

This confirmed the critical role of IL-1 in preventing the migration of Candida albicans from its natural habitats in the mouth and gut to other organs. The researchers emphasize that while the study focused on Candida albicans, the IL-1 pathway may serve as a broader defense mechanism against other fungal species that commonly inhabit healthy microbiomes.

If validated in human trials, the findings could lead to a diagnostic test identifying patients at risk of fatal fungal infections, allowing for early intervention and potentially preventing severe disease. The study's authors hope their work will pave the way for more targeted therapies and eventually, a vaccine against fungal infections, which currently affect over 1 billion people worldwide and lack approved treatments.